Oct 2024 Articles

Articles
Hypercholesterolemia and inflammation-Cooperative cardiovascular risk factors
Gallo A, Le Goff W, Santos RD, et al.
Journal:
Eur J Clin Invest

First published: October 6, 2025 DOI: 10.1111/eci.14326
View
- Share
Articles
Evaluating obicetrapib as an emerging treatment for patients with dyslipidemia: a game changer?
Nicholls SJ, Tan S, Butters J, et al.
Journal:
Expert Opin Pharmacother

First published: October 25, 2024 DOI: 10.1080/14656566.2024.2409324
View
- Share
Articles
LDL-C and hs-CRP Jointly Modify the Effect of Lp(a) on 5-Year Death in Patients With Percutaneous Coronary Intervention
Li J, Yan K, Zhu P, et al.
Journal:
Clin Cardiol

First published: October 21, 2024 DOI: 10.1002/clc.70025
View
- Share
Articles
Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial
van der Aalst CM, Denissen SJAM, Vonder M, et al.
Journal:
Eur Heart J Cardiovasc Imaging

First published: October 20, 2024 DOI: 10.1093/ehjci/jeaa168
View
- Share
Articles
Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease
Shah NP, Mulder H, Lydon B, et al.
Journal:
Am Heart J

First published: October 16, 2024 DOI: 10.1016/j.ahj.2024.10.009
View
- Share
Articles
Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation
Nicholls SJ, Manmathan GP
Journal:
Atherosclerosis

First published: October 11, 2024 DOI: 10.1016/j.atherosclerosis.2024.118628
View
- Share
Articles
Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases
Potere N, Bonaventura A, Abbate A
Journal:
Arterioscler Thromb Vasc Biol

First published: October 10, 2024 DOI: 10.1161/ATVBAHA.124.319980
View
- Share
Articles
Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis
Carvalho PEP, Gewehr DM, Nascimento BR, et al.
Journal:
JAMA Cardiol

First published: October 9, 2024 DOI: 10.1001/jamacardio.2024.3216
View
- Share
Articles
Influence of Subclinical Atherosclerosis Burden and Progression on Mortality
Fuster V, García-Álvarez A, Devesa A, et al.
Journal:
J Am Coll Cardiol

First published: October 8, 2024 DOI: 10.1016/j.jacc.2024.06.045
View
- Share
Articles
Within-person stability of lipoprotein(a) concentration
Ghouse J, Ahlberg G, Albertsen Rand S, et al.
Journal:
Eur Heart J

First published: October 8, 2024 DOI: 10.1093/eurheartj/ehae652
View
- Share
Articles
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)
Journal:
Lancet Diabetes Endocrinol

First published: October 3, 2024 DOI: 10.1016/S2213-8587(24)00221-3
View
- Share

Oct 2024 Articles

Articles

Hypercholesterolemia and inflammation-Cooperative cardiovascular risk factors

Gallo A, Le Goff W, Santos RD, et al.

Articles

Evaluating obicetrapib as an emerging treatment for patients with dyslipidemia: a game changer?

Nicholls SJ, Tan S, Butters J, et al.

Articles

LDL-C and hs-CRP Jointly Modify the Effect of Lp(a) on 5-Year Death in Patients With Percutaneous Coronary Intervention

Li J, Yan K, Zhu P, et al.

Articles

Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial

van der Aalst CM, Denissen SJAM, Vonder M, et al.

Articles

Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease

Shah NP, Mulder H, Lydon B, et al.

Articles

Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation

Nicholls SJ, Manmathan GP

Articles

Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases

Potere N, Bonaventura A, Abbate A

Articles

Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

Carvalho PEP, Gewehr DM, Nascimento BR, et al.

Articles

Influence of Subclinical Atherosclerosis Burden and Progression on Mortality

Fuster V, García-Álvarez A, Devesa A, et al.

Articles

Within-person stability of lipoprotein(a) concentration

Ghouse J, Ahlberg G, Albertsen Rand S, et al.

Articles

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)

Articles

Hypercholesterolemia and inflammation-Cooperative cardiovascular risk factors

Gallo A, Le Goff W, Santos RD, et al.

Share

Articles

Evaluating obicetrapib as an emerging treatment for patients with dyslipidemia: a game changer?

Nicholls SJ, Tan S, Butters J, et al.

Share

Articles

LDL-C and hs-CRP Jointly Modify the Effect of Lp(a) on 5-Year Death in Patients With Percutaneous Coronary Intervention

Li J, Yan K, Zhu P, et al.

Share

Articles

Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial

van der Aalst CM, Denissen SJAM, Vonder M, et al.

Share

Articles

Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease

Shah NP, Mulder H, Lydon B, et al.

Share

Articles

Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation

Nicholls SJ, Manmathan GP

Share

Articles

Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases

Potere N, Bonaventura A, Abbate A

Share

Articles

Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

Carvalho PEP, Gewehr DM, Nascimento BR, et al.

Share

Articles

Influence of Subclinical Atherosclerosis Burden and Progression on Mortality

Fuster V, García-Álvarez A, Devesa A, et al.

Share

Articles

Within-person stability of lipoprotein(a) concentration

Ghouse J, Ahlberg G, Albertsen Rand S, et al.

Share

Articles

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)

Share